Wealth Enhancement Advisory Services LLC Invests $155,000 in Agilon Health, Inc. (NYSE:AGL)

Wealth Enhancement Advisory Services LLC acquired a new stake in Agilon Health, Inc. (NYSE:AGLFree Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 81,831 shares of the company’s stock, valued at approximately $155,000.

Several other institutional investors also recently bought and sold shares of the business. Vanguard Group Inc. boosted its holdings in Agilon Health by 0.9% during the 4th quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company’s stock valued at $59,114,000 after acquiring an additional 272,787 shares during the period. Capital International Investors increased its holdings in shares of Agilon Health by 72.0% in the 4th quarter. Capital International Investors now owns 22,331,873 shares of the company’s stock valued at $42,431,000 after acquiring an additional 9,346,295 shares during the last quarter. Millennium Management LLC increased its holdings in shares of Agilon Health by 187.8% in the 4th quarter. Millennium Management LLC now owns 7,212,525 shares of the company’s stock valued at $13,704,000 after acquiring an additional 4,706,357 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Agilon Health by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company’s stock valued at $13,168,000 after acquiring an additional 35,207 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in Agilon Health by 49.2% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company’s stock worth $8,629,000 after buying an additional 1,498,524 shares during the last quarter.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the company. Royal Bank Of Canada raised their price target on Agilon Health from $3.00 to $3.50 and gave the stock an “outperform” rating in a research note on Wednesday, February 26th. Barclays raised their price target on Agilon Health from $2.00 to $3.00 and gave the stock an “underweight” rating in a research note on Thursday, May 8th. Robert W. Baird dropped their price target on Agilon Health from $6.00 to $5.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 15th. The Goldman Sachs Group raised their price target on Agilon Health from $2.50 to $5.00 and gave the stock a “neutral” rating in a research note on Thursday, May 8th. Finally, Sanford C. Bernstein upgraded Agilon Health from a “market perform” rating to an “outperform” rating and raised their price target for the stock from $3.30 to $8.50 in a research note on Tuesday, April 8th. Two equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, Agilon Health currently has an average rating of “Hold” and an average target price of $4.79.

Read Our Latest Stock Analysis on AGL

Agilon Health Price Performance

AGL opened at $2.12 on Wednesday. The business has a 50 day simple moving average of $3.23 and a 200-day simple moving average of $3.21. The stock has a market capitalization of $875.50 million, a P/E ratio of -3.58 and a beta of 0.14. Agilon Health, Inc. has a 12 month low of $1.50 and a 12 month high of $7.73.

Agilon Health (NYSE:AGLGet Free Report) last posted its quarterly earnings results on Tuesday, May 6th. The company reported $0.03 EPS for the quarter, beating the consensus estimate of ($0.01) by $0.04. The business had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.50 billion. Agilon Health had a negative return on equity of 45.47% and a negative net margin of 4.04%. The company’s quarterly revenue was down 4.5% compared to the same quarter last year. During the same period last year, the firm earned ($0.02) EPS. Research analysts anticipate that Agilon Health, Inc. will post -0.59 EPS for the current year.

Agilon Health Company Profile

(Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Recommended Stories

Want to see what other hedge funds are holding AGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilon Health, Inc. (NYSE:AGLFree Report).

Institutional Ownership by Quarter for Agilon Health (NYSE:AGL)

Receive News & Ratings for Agilon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilon Health and related companies with MarketBeat.com's FREE daily email newsletter.